Finally, the reduced bioavailability of NO, either by inhibition of eNOS or activation of iNOS, is associated with several cardiovascular diseases and conditions, such coronary diseases, atherosclerosis, and hypertension [78]. This evidence concerns the gene NOS3 and hypertensive disorder.